TITLE

A flawed cancer study's latest casualty

PUB. DATE
April 1994
SOURCE
U.S. News & World Report;4/11/94, Vol. 116 Issue 14, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that oncologist Bernard Fisher, dogged by accusations of ignoring a colleague's fraudulent data, was forced to step down as head of a group of landmark breast and colon cancer clinical trials. Revelation that a Montreal doctor had submitted falsified data which led to widespread acceptance of lumpectomy plus radiation over mastectomy; Fisher's failure to publish a reanalysis.
ACCESSION #
9404057514

 

Related Articles

  • ORI finds no misconduct in Fisher case.  // JNCI: Journal of the National Cancer Institute;04/02/97, Vol. 89 Issue 7, p472 

    Reports that the Office of Research Integrity (ORI) of the Department of Health and Human Services found no evidence of scientific misconduct by Bernard Fisher in his capacity as the principal investigator of the National Surgical Adjuvant Breast and Bowel Project. Issue of the publication of...

  • Cancer researcher is cleared of misconduct.  // Nature;3/13/1997, Vol. 386 Issue 6621, p104 

    Reports on the decision by the US Department of Health and Human Services' Office of Research Integrity to clear cancer researcher Bernard Fisher of charges of scientific misconduct. Fishers' work with the National Surgical Adjuvant Breast and Bowel Project.

  • Exonerated researcher settles for $3m. Wadman, Meredith // Nature;9/4/1997, Vol. 389 Issue 6646, p3 

    Reports that cancer researcher Bernard Fisher has won $2.75 million in damages and an apology from the University of Pittsburgh. Fisher's suit following dismissal and accusations of scientific misconduct; National Cancer Institute's contribution to damages; Details of lawsuit; Comments from Fisher.

  • Congressional hearing delves into NSABP fraud issues. Jenks, Susan // JNCI: Journal of the National Cancer Institute;5/4/94, Vol. 86 Issue 9, p664 

    Reports on criticisms of Bernard Fisher, head of the National Surgical Adjuvant Breast and Bowel Project (NSABP), for alleged laxity in publishing corrections to fraud-tainted breast cancer studies. Conducting of congressional hearing on scientific misconduct.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics